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Background:
Meningococcal disease is a major health problem worldwide. Neisseria meningitidis is a major cause of meningitis and septicaemia globally, predominantly affecting children and adolescents. Disease develops rapidly and often difficult to distinguish from other febrile illnesses. Meningococcal meningitis and sepsis are devastating diseases that kills children and young adults within hours despite the availability of effective antibiotics. Mortality and permanent disability rates are high, even under optimal health care conditions [1] . Therefore, any further reduction in morbidity and mortality is most likely to be achieved through prophylactic vaccination. The sole ecological niche of Neisseria meningitidis is mucosa of the oropharynx of humans. Meningococcal colonization of the respiratory tract, a phenomenon commonly referred to as carriage, represents a successful commensal relationship between the host and the bacterium, with the host experiencing no detectable pathology. On the other hand disease represents a failed or dysfunctional relationship with the host. Acquistion of Neisseria meningitidis demands person to person transmission via direct contact or through dispersion of respiratory droplets from an infected to a susceptible individual. Although, often protected by a polysaccharides capsule, meningococci are particularly sensitive to desiccation; thus spread from one individual to another requires close contact [2] .
The causative agent, Neisseria meningitidis, is a Gram-negative encapsulated bacterium classified into different groups according to the chemical composition and immunogenic properties of the capsular polysaccharide. Serogroups A, B, C, W135, and Y account for >95% of infections. Effective vaccines consisting of capsular polysaccharide or capsular polysaccheride-cojugates are available for the prevention of infections caused by serogroup A, C, Y, and W135 strains [3, 4] . However, no capsule-based vaccine is available for the prevention of infections caused by N. meningitidis serogroup B, which is highly prevalent in industrialized countries. This problem is caused by the poor immunogenicity of the serogroup B capsular polysaccharide. It is likely that the immune system tolerates the serogroup B capsular polysaccharide because of its similarity or mimicry to the widely distributed human carbohydrate α(2→8)N-acetyl neuraminic acid or polysialic acid, both consisting of repeating units of two to eight linked sialic acid [5] . Therefore, for the development of an effective vaccine against serogroup B meningococci, researchers have focused on the proteins of the outer membrane (OM). Bioinformatics tools can be used to screen MHC-peptide complexes that become potential T-cell epitopes used for the development of peptidebased epitope vaccines [17] . A peptide which has a proteosomal recognition site may not be useful as epitope vaccine candidate because it is degraded during antigen processing [18] . Therefore methods for predicting the proteasomal cleavage sites were incorporated in algorithms used for predicting T-cell epitopes [19] . Four fundamental properties of proteasomes are: (i) the broad cleavage-site specificity; (ii) the enhanced preference for hydrophobic residues in a hydrophobic sequence context; (iii) the excision of large numbers of peptide ≥ 8 amino acids; and (iv) the versatility of proteasomal processing resulting in overlapping peptide patterns. The aim of this study is to predict epitope peptides that bind with class I and class II MHC molecules, and will be useful for the prediction of new peptide molecules for vaccine design. 
Methodology
A(9);Score P(1)= P(1)+A(2)+C(3)+D(4)+P(5)+G(6)+R (7)+A (8)+A (9) Where 'P (1)' is score of amino acid 'P' at position 1.
For the prediction of the MHC binders the score of these 9mer peptides were calculated using quantitative matrix of selected MHC alleles. The all peptides having scored greater than selected threshold score (at 4%) were assigned as predicted binders for selected MHC alleles. For prediction of proteasome cleavage site overlapping 12mer peptides were calculated using weight matrix of proteasome. All peptides having score greater than selected threshold score (at 5%) are considered as peptides having proteasome cleavage site. Similar approach is used for prediction of peptides having immunoproteasome cleavage site [17, 19] . In order to calculate threshold score for each allele/matrix, the steps used were:
1. All proteins were obtained from SWISSPROT database for creating the overlapping peptides of length nine. For example, a protein of length n will have (n+1 -9) overlapping peptides.
2. The score of all natural 9-mer peptides was calculated using the weighed matrix of that allele. These peptides have been sorted on the basis of score in descending order and top 1% natural peptides have been extracted. The minimum score that we called threshold score was determined from these selected peptides. Similarly, threshold scores at 2%, 3% … 10% were calculated. The following threshold dependent parameters were used for the evaluation of tools ProPred and ProPred1: Sensitivity= TP/(TP+FN); Specificity= TN/(TN+FP); Accuracy= (TP+TN)/(TP+FN+TN+FP). Where, TP and TN are correctly predicted binders and non-binders respectively, whereas FP and FN are wrongly predicted binders and non binders respectively from the database MHCBN [23].
The IC50 value of corresponding peptides is deduced by MHCPred [24-25].
IC50 value of allele HLA_A*0101 for MHC class I peptides and IC50 value of HLA_DRB1*0101 for MHC class II peptides. The predicted output is given in units of IC50 nM.
Discussion:
The physiochemical properties of proteins are given in (Table 1 .see supplementary material.) The pI values of all these OM proteins indicated the stability of protein at that particular pI. The theoretical pI of the proteins identified ranged from 4.79 to 9.71 and theoretical MW ranged from 18.4 to 159.9. This information is useful for the proteomics study especially for the 2D PAGE and is also useful for cataloguing OMV proteins with emphasis on 15 OM proteins used in this study. Outer membrane proteins are notoriously difficult to resolve by 2D PAGE. By their nature, hydrophobic proteins are often difficult to solubilise and are least soluble when focused at their pI. The antigenicity of all the OM proteins predicted using VaxiJen server is given in (Figure 1 and Table 2 The summary of the results of the prediction tools ProPred and ProPred1 used for the HTL and CTL epitopes identification respectively in the present study are being made available at (http://www.bioinfoindia.org/epitopes/HTL_CTL_Table.pdf). According to the prediction results of MHCPred, peptides with the best predicted binding affinities of HLA_A*0101 for MHC class I and HLA_DRB*0101 for MHC class II molecules are also presented therein. The predicted output is given in units of IC50 nM. A lower value of peptide IC50 indicates higher affinity towards MHC molecules. Peptides with IC50 values < 50nM, < 500nM, and <5000nM are considered having high affinity, intermediate affinity and low affinity towards MHC molecules respectively (HTL_CTL_Table.pdf). In OMV 236 nonredundent proteins have been identified out of which 15 (6.4%) proteins were predicted to be located in the outer membrane. From BlastP results it is established that 13 out of 15 OM proteins are the most suitable for the vaccines and they contain maximum promiscuous epitopes at many HLA alleles as these 13 OM proteins didn't show any significant similarity with human proteins and neglect the chances of autoimmunity response. A multiple promiscuous target peptide epitopes would overcome the genetic restriction, low immunological responsiveness and parasite evasion of the immune response and provide support for developing a multistage, multivalent, universal, safe, stable and effective meningococcal vaccine.
The OM proteins contain a porins, porA and porB, which are used for serotyping and serosubtyping of meningococci. The most abundant of these included proteins with important biological function, including the porA and porB porins, opc is involved in the adhesion of the meningococci to host cell-surface proteoglycan and therefore plays a part in colonisation and invasion by bacterium. This protein associated with invasion of epithelial and endothelial cells [26] . The rmpM protein, which may protect against complement-mediated bactericidal attack [27], mtrE is one of four proteins encoded by the multiple transferable resistance mtrE locus and forms outer membrane component of multidrug efflux pump [28] , outer membrane protein nspA and pilQ which is essential for pilus assembly [29] . Two hypothetical proteins NMB0345 and NMB0088 are identified in the outer membrane protein constituent of OMV. Some other major OM proteins are also present like hap for adhesion and penetration, lptD involved in the assembly of LPS in the outer leaflet of the outer membrane, determines N-hexane tolerance and is involved in outer membrane permeability, essential for envelope biogenesis, thpB acts as a transferrin receptor and is required for transferrin utilization.
The peptides of 13 antigenic proteins are classified into binding and nonbinding groups. The binding peptides signify the predicted epitopes and non-binding peptide signifies the protein sequence of OM protein minus binding sequence. Both dataset constructed for the MHC class I and class II individually. Then amino acid composition is computed and results are evaluated in three category of amino acid: hydrophobic, charged and polar and other small amino acid. Our data illustrate (Figure 2, 3 ) that hydrophobic amino acids are found more frequently in binding group (epitope) than in the non-binding group. The non binding group have more polar amino acid compared to other amino acids. This condition is found in both CTL as well as in the HTL binding and non binding dataset (Table 3 see supplementary material). Based on our analysis a computational protocol (Figure. 4 ) has been proposed which will work as a model for such further studies. The predicted epitopes in OMV proteins would be useful for the earlier identification of meningitis and septicaemia, and will be helpful used for secure vaccine development against meningococcal diseases. 
Conclusion:
Predicted promiscuous HTL and CTL epitopes from the genome/proteome sequences of the pathogens would greatly reduced the time as well as cost and is useful for experiment planning in development of peptide-based epitope vaccines. We have predicted numerous epitopes in OMV proteins which would be useful for the earlier identification of meningitis and septicaemia, the predicted epitopes may be used for safe vaccine development against meningococcal diseases. Results indicate that porA, porB, opc, rmpM, mtrE and nspA are more suitable vaccine candidates. These six proteins are selected due to their smaller size and most important thing is that they are present most abundantly in the OMV proteins as an outer membrane proteins. We frequently found large number of hydrophobic amino acid, certain polar and charged amino acids in binding group. Hydrophobic protein regions may tend to be highly conserved because of their importance for correct folding they may show epitopes particularly effective for protective host immunity. Also they have variable pI which is important for 2D study for separation of proteins. These results have important propositions for the development and use of vaccines based on epitopes of OM proteins after in vitro study and experimental validation.
